Paige Chamberlain
Stock Analyst at Wolfe Research
(1.74)
# 3,244
Out of 4,423 analysts
5
Total ratings
66.7%
Success rate
3.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paige Chamberlain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Rated: Buy | $55 | $53.63 | +2.55% | 1 | Jun 1, 2026 | |
| NTRA Natera | Rated: Buy | $260 | $231.41 | +12.35% | 1 | Jun 1, 2026 | |
| GH Guardant Health | Rated: Buy | $150 | $131.78 | +13.83% | 1 | Jun 1, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | n/a | $63.74 | - | 1 | Jun 1, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | n/a | $50.84 | - | 1 | Jun 1, 2026 |
Veracyte
Jun 1, 2026
Rated: Buy
Price Target: $55
Current: $53.63
Upside: +2.55%
Natera
Jun 1, 2026
Rated: Buy
Price Target: $260
Current: $231.41
Upside: +12.35%
Guardant Health
Jun 1, 2026
Rated: Buy
Price Target: $150
Current: $131.78
Upside: +13.83%
GRAIL
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $63.74
Upside: -
Tempus AI
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $50.84
Upside: -